Unknown,Transcriptomics,Genomics,Proteomics

Dataset Information

0

Transcriptional targets of oncogenic RAS proteins that mediate their ability to induce cellular transformation


ABSTRACT: Mutations in the NRAS oncogene are present in up to 20% of melanoma. Here, we show that interferon alpha-inducible protein 6 (IFI6) is necessary for NRASQ61K-induced transformation and melanoma growth. IFI6 was transcriptionally upregulated by NRASQ61K, and knockdown of IFI6 resulted in DNA replication stress due to dysregulated DNA replication via E2F2. This stress consequentially inhibited cellular transformation and melanoma growth via senescence or apoptosis induction depending on the RB and p53 pathway status of the cells. NRAS-mutant melanoma were significantly more resistant to the cytotoxic effects of DNA replication stress-inducing drugs, and knockdown of IFI6 increased sensitivity to these drugs. Pharmacological inhibition of IFI6 expression by the MEK inhibitor trametinib, when combined with DNA replication stress-inducing drugs, blocked NRAS-mutant melanoma growth. Collectively, we demonstrate that IFI6, via E2F2 regulates DNA replication and melanoma development and growth, and this pathway can be pharmacologically targeted to inhibit NRAS-mutant melanoma. MEL-ST cells expressing either empty vector or mutant oncogenic RAS genes (HRAS v12, KRAS v12, NRAS Q61K) were used to isolate total RNA. The RNA was then used to perform gene expression analyses using the Illumina HumanHT-12 V4.0 Expression BeadChip array.

ORGANISM(S): Homo sapiens

SUBMITTER: narendra wajapeyee 

PROVIDER: E-GEOD-62827 | biostudies-arrayexpress |

REPOSITORIES: biostudies-arrayexpress

Similar Datasets

2016-09-08 | E-GEOD-69933 | biostudies-arrayexpress
2016-09-08 | GSE69933 | GEO
2016-09-08 | GSE62827 | GEO
2024-09-20 | PXD046277 | Pride
2024-09-19 | PXD051431 | Pride
2014-09-19 | E-GEOD-61544 | biostudies-arrayexpress
2022-04-27 | PXD032224 | Pride
2018-06-25 | PXD008010 | Pride
2023-11-14 | GSE245262 | GEO
2022-03-23 | PXD007649 | Pride